Nucleostemin is a marker of proliferating stromal stem cells in adult human bone marrow

¹ Academic Rheumatology, Department of Clinical Science at North Bristol, University of Bristol, United Kingdom

^* To whom correspondence should be addressed. E-mail: w.z.kafienah{at}bristol.ac.uk.

	Abstract

The identification of stem-cell-specific proteins and the elucidation of their novel regulatory pathways may help in the development of protocols for control of their selfrenewal and differentiation for cell based therapies. Nucleostemin is a recently discovered nucleolar protein predominantly associated with proliferating rat neural and embryonic stem cells, and some human cancer cell lines. A comprehensive study of nucleostemin in human adult bone marrow stem cells is lacking. The aim of the study was to determine if nucleostemin is synthesised by adult bone marrow stem cells and to analyse its expression during their expansion and differentiation. Using a multipotential adherent population of stem cells, nucleostemin was localized to the nucleoli and occurred in 43.3% of the cells. There was a high level of expression of nucleostemin mRNA in bone marrow stem cells and this remained unchanged over time during cell expansion in culture. When bone marrow stem cells were stimulated to proliferate by FGF-2, nucleostemin expression increased in a dose-dependent manner. siRNA knockdown of nucleostemin abolished the proliferative effect of FGF-2. When bone marrow stem cells were differentiated into chondrocytes, adipocytes or osteocytes, nucleostemin expression decreased by 70-90% compared to the undifferentiated cells retained in monolayer culture. We conclude that nucleostemin is a marker of undifferentiated human adult bone marrow stem cells and that it is involved in the regulation of proliferation of these cells.

This article has been cited by other articles:

				M. Tjwa and S. Dimmeler A Nucleolar Weapon in Our Fight for Regenerating Adult Hearts: Nucleostemin and Cardiac Stem Cells Circ. Res., July 3, 2008; 103(1): 4 - 6. [Full Text] [PDF]

				S. Siddiqi, N. Gude, T. Hosoda, J. Muraski, M. Rubio, G. Emmanuel, J. Fransioli, S. Vitale, C. Parolin, D. D'Amario, et al. Myocardial Induction of Nucleostemin in Response to Postnatal Growth and Pathological Challenge Circ. Res., July 3, 2008; 103(1): 89 - 97. [Abstract] [Full Text] [PDF]

				J. Fransioli, B. Bailey, N. A. Gude, C. T. Cottage, J. A. Muraski, G. Emmanuel, W. Wu, R. Alvarez, M. Rubio, S. Ottolenghi, et al. Evolution of the c-kit-Positive Cell Response to Pathological Challenge in the Myocardium Stem Cells, May 1, 2008; 26(5): 1315 - 1324. [Abstract] [Full Text] [PDF]

				D. L. Troyer and M. L. Weiss Concise Review: Wharton's Jelly-Derived Cells Are a Primitive Stromal Cell Population Stem Cells, March 1, 2008; 26(3): 591 - 599. [Abstract] [Full Text] [PDF]

				W. Kafienah, S. Mistry, M. J. Perry, G. Politopoulou, and A. P. Hollander Pharmacological Regulation of Adult Stem Cells: Chondrogenesis Can Be Induced Using a Synthetic Inhibitor of the Retinoic Acid Receptor Stem Cells, October 1, 2007; 25(10): 2460 - 2468. [Abstract] [Full Text] [PDF]

				H. Yasumoto, L. Meng, T. Lin, Q. Zhu, and R. Y. L. Tsai GNL3L inhibits activity of estrogen-related receptor {gamma} by competing for coactivator binding J. Cell Sci., August 1, 2007; 120(15): 2532 - 2543. [Abstract] [Full Text] [PDF]

				Q. Zhu, H. Yasumoto, and R. Y. L. Tsai Nucleostemin Delays Cellular Senescence and Negatively Regulates TRF1 Protein Stability Mol. Cell. Biol., December 15, 2006; 26(24): 9279 - 9290. [Abstract] [Full Text] [PDF]

				C. Beekman, M. Nichane, S. De Clercq, M. Maetens, T. Floss, W. Wurst, E. Bellefroid, and J.-C. Marine Evolutionarily Conserved Role of Nucleostemin: Controlling Proliferation of Stem/Progenitor Cells during Early Vertebrate Development Mol. Cell. Biol., December 15, 2006; 26(24): 9291 - 9301. [Abstract] [Full Text] [PDF]